We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phototherapy Threshold: Changes Between 2004 and 2022 AAP Guidelines.
- Authors
Bottu, Archana; Manzar, Shabih
- Abstract
Jaundice is commonly seen in newborns as the physical manifestation of hyperbilirubinemia (HB), which may be treated with phototherapy. Pediatricians follow the American Academy of Pediatrics (AAP) Phototherapy (PTx) guidelines for HB management. AAP launched new guidelines in 2022, raising concerns amongst some pediatricians about leniency before starting phototherapy. A general notion of the new PTx guideline is that newborns are at an increased risk for delayed intervention or a greater readmission potential due to an earlier discharge. We compared hourly phototherapy threshold levels between the previous and the 2022 AAP guidelines to investigate this possibility. Thresholds for infants with a gestational age of 38 weeks within the first 48 hours of life were used to represent the newborns most commonly seen in the nursery. We then generated graphs representing the values and their differences. The differences ranged from 0.5 to 1.8 mg/dL in the group without risk factors and 0.3--1.8 mg/dL in the group with neurotoxicity risk factors. We concluded that the new AAP 2022 phototherapy nomogram is comparable to the old 2004 AAP nomogram. This study should be replicated to compare individual nomograms for 35, 36, 37, 39, and 40 weeks of gestational age.
- Subjects
MEDICAL protocols; PATIENT readmissions; BLOOD-brain barrier; BILIRUBIN; PHOTOTHERAPY; AMERICAN Academy of Pediatrics; GESTATIONAL age; NEONATAL jaundice; ABO blood group system; DISEASE complications; CHILDREN
- Publication
Neonatology Today, 2024, Vol 19, Issue 4, p25
- ISSN
1932-7129
- Publication type
Article